Other
Payments to Acquire Property, Plant, and Equipment
Year-over-year, this metric declined by 15.0%, from $10.70M to $9.10M. Over 3 years (FY 2021 to FY 2025), Payments to Acquire Property, Plant, and Equipment shows an upward trend with a 15.9% CAGR.
Analysis
StatementIncome Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026May 5, 2026
How to read this metric
High levels indicate aggressive investment in expansion or maintenance, while low levels may suggest capital preservation or reduced growth investment.
Detailed definition
Measures the cash outflows used to purchase or construct long-term physical assets, such as machinery, facilities, and i...
Peer comparison
Standard capital expenditure (CapEx) metric used across all industries to evaluate investment strategy.
Metric ID:
other_payments_to_acquire_property_plant_and_equipmentHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.30M | $5.70M | $8.90M | $7.60M | $8.80M | $1.80M | $8.50M | $6.80M | $7.60M | $5.40M | $11.20M | $11.60M | $8.10M | $7.30M | $10.70M | $12.50M | $13.20M | $0.00 | $9.10M |
| QoQ Change | — | +32.6% | +56.1% | -14.6% | +15.8% | -79.5% | +372.2% | -20.0% | +11.8% | -28.9% | +107.4% | +3.6% | -30.2% | -9.9% | +46.6% | +16.8% | +5.6% | -100.0% | — |
| YoY Change | — | — | — | — | +104.7% | -79.8% | +11.8% | -22.7% | — | +200.0% | +31.8% | +70.6% | +6.6% | +35.2% | -4.5% | +7.8% | +63.0% | -100.0% | -15.0% |
Range$0.00 – $13.20M
CAGR+18.1%
Avg YoY Growth+22.1%
Median YoY Growth+9.8%
Current Streak2 quarters decline
Payments to Acquire Property, Plant, and Equipment at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's payments to acquire property, plant, and equipment?
- Neurocrine Biosciences (NBIX) reported payments to acquire property, plant, and equipment of $9.10M in Q1 2026.
- How has Neurocrine Biosciences's payments to acquire property, plant, and equipment changed year-over-year?
- Neurocrine Biosciences's payments to acquire property, plant, and equipment decreased by 15.0% year-over-year, from $10.70M to $9.10M.
- What is the long-term trend for Neurocrine Biosciences's payments to acquire property, plant, and equipment?
- Over 3 years (2021 to 2025), Neurocrine Biosciences's payments to acquire property, plant, and equipment has grown at a 15.9% compound annual growth rate (CAGR), from $23.40M to $36.40M.
- What does payments to acquire property, plant, and equipment mean?
- The amount of cash spent on buying or building long-term physical assets like factories and equipment.